Publicacions en què col·labora amb Óscar Rafael Estupiñán Sánchez (9)

2023

  1. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling

    Biomedicine and Pharmacotherapy, Vol. 162

2022

  1. Addressing Doxorubicin Resistance in Bone Sarcomas using Novel Drug‐Resistant Models

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  2. Proof of concept for the use of trained sniffer dogs to detect osteosarcoma

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Mithramycin delivery systems to develop effective therapies in sarcomas

    Journal of Nanobiotechnology, Vol. 19, Núm. 1

  2. Nano-encapsulation of mithramycin in transfersomes and polymeric micelles for the treatment of sarcomas

    Journal of Clinical Medicine, Vol. 10, Núm. 7

2020

  1. Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications

    Cancers, Vol. 12, Núm. 4

2019

  1. New chondrosarcoma cell lines with preserved stem cell properties to study the genomic drift during in vitro/in vivo growth

    Journal of Clinical Medicine, Vol. 8, Núm. 4

  2. The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas

    International Journal of Cancer, Vol. 145, Núm. 1, pp. 254-266

2018

  1. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

    Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56